Distinct Roles for Bruton's Tyrosine Kinase in B Cell Immune Synapse Formation

被引:13
作者
Roman-Garcia, Sara [1 ]
Merino-Cortes, Sara V. [1 ]
Gardeta, Sofia R. [1 ]
de Bruijn, Marjolein J. W. [2 ]
Hendriks, Rudi W. [2 ]
Carrasco, Yolanda R. [1 ]
机构
[1] CSIC, CNB, Dept Immunol & Oncol, Cell Dynam Lab B, Madrid, Spain
[2] Erasmus Univ, Dept Pulm Med, Med Ctr, Rotterdam, Netherlands
关键词
B cells; Btk; immune synapse; actin cytoskeleton; shuttling/scaffold; kinase; cell activation; PROTEIN-DEFICIENCY; ACTIVATION; BTK; ADHESION; ANTIGEN; ACTIN; LYMPHOCYTES; DYNAMICS; TEC; EXPRESSION;
D O I
10.3389/fimmu.2018.02027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bruton's tyrosine kinase (Btk) has a key role in the signaling pathways of receptors essential for the B lymphocyte response. Given its implication in B cell-related immunodeficiencies, leukemias/lymphomas and autoimmunity, Btk is studied intensely and is a target for therapy. Here, using primary B cells from distinct mouse models and the pharmacological inhibitors ibrutinib and acalabrutinib, we report distinct roles for Btk in antigen-triggered immune synapse (IS) formation. Btk recruitment to the plasma membrane regulates the B cell ability to trigger IS formation as well as its appropriate molecular assembly; Btk shuttling/scaffold activities seem more relevant than the kinase function on that. Btk-kinase activity controls antigen accumulation at the IS through the PLC gamma 2/Ca2+ axis. Impaired Btk membrane-recruitment or kinase function likewise alters antigen-triggered microtubule-organizing center (MTOC) polarization to the IS, B cell activation and proliferation. Data also show that, for B cell function, IS architecture is as important as the quantity of antigen that accumulates at the synapse.
引用
收藏
页数:16
相关论文
共 50 条
[31]   Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders [J].
Castillo, Jorge J. ;
Treon, Steven P. ;
Davids, Matthew S. .
CANCER JOURNAL, 2016, 22 (01) :34-39
[32]   Bruton's Tyrosine Kinase is involved in innate and adaptive immunity [J].
Brunner, C ;
Müller, B ;
Wirth, T .
HISTOLOGY AND HISTOPATHOLOGY, 2005, 20 (03) :945-955
[33]   Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis [J].
Chen, Jin-Shuen ;
Chang, Li-Chien ;
Huang, Shyh-Jer ;
Cheng, Chao-Wen .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[34]   Bruton's tyrosine kinase (Btk) - the critical tyrosine kinase in LPS signalling? [J].
Jefferies, CA ;
O'Neill, LAJ .
IMMUNOLOGY LETTERS, 2004, 92 (1-2) :15-22
[35]   Functions of Bruton's tyrosine kinase in mast and B cells [J].
Kawakami, Y ;
Kitaura, J ;
Hata, D ;
Yao, LB ;
Kawakami, T .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (03) :286-290
[36]   Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways [J].
Langlois, Julie ;
Lange, Simona ;
Ebeling, Martin ;
Macnair, Will ;
Schmucki, Roland ;
Li, Cenxiao ;
Degeer, Jonathan ;
Sudharshan, Tania J. J. ;
Yong, V. Wee ;
Shen, Yun-An ;
Harp, Christopher ;
Collin, Ludovic ;
Keaney, James .
JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
[37]   The role of Bruton's tyrosine kinase inhibitors in the management of mantle cell lymphoma [J].
Hanna, Kirollos S. ;
Campbell, Maren ;
Husak, Alex ;
Sturm, Sabrina .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) :1190-1199
[38]   T-cell expression of Bruton's tyrosine kinase promotes autoreactive T-cell activation and exacerbates aplastic anemia [J].
Xia, Simo ;
Liu, Xiang ;
Cao, Xuetao ;
Xu, Sheng .
CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (10) :1042-1052
[39]   Single cell imaging of Bruton's Tyrosine Kinase using an irreversible inhibitor [J].
Turetsky, Anna ;
Kim, Eunha ;
Kohler, Rainer H. ;
Miller, Miles A. ;
Weissleder, Ralph .
SCIENTIFIC REPORTS, 2014, 4
[40]   Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma [J].
Fernandez-Vega, Ivan ;
Quiros, Luis M. ;
Santos-Juanes, Jorge ;
Pane-Foix, Maria ;
Marafioti, Teresa .
VIRCHOWS ARCHIV, 2015, 466 (02) :229-235